MedCity News June 21, 2024
Underrepresentation of racial and ethnic groups and other historically disenfranchised populations in clinical trials continues to be a major challenge. Medical Affairs can help identify solutions.
The pharmaceutical industry has evolved significantly in the past few decades to better meet the needs of today’s patients. Since I left my medical practice to join the industry 15 years ago, the role of Medical Affairs has changed significantly with this evolution. It has moved from a function primarily supporting recruitment in Research and Development (R&D) clinical trials and educating the data that these trials produce, to a function that is integrated along all phases of drug development and commercialization. As we continue in this expanded capacity, we also have an opportunity to...
Today's Sponsors
Today's Sponsor